Peking University First Hospital

Urology (泌尿外科): Peking University First Hospital is renowned as the birthplace and leader of urology in China, having established the country's first Urology Department in 1946. Over its history, two generations of distinguished academicians, including Wu Jieping, have contributed to its excellence. The department pioneered the first renal transplant in China in 1960. It possesses extensive experience and profound expertise in the diagnosis and treatment of a wide range of urological conditions, including urogenital tumors, prostate diseases, urinary control issues, male genital diseases, and urinary calculi. Additionally, Urology is one of the ten departments actively utilizing the hospital's new Day Surgery Center, which offers 491 types of procedures.

Nephrology (肾脏内科): The Nephrology department at Peking University First Hospital is recognized as a national clinical key specialty and holds a leading position in China for the diagnosis, treatment, and research of kidney diseases. It was the first institution in China to establish a major in Nephrology in 1950. The department excels in the in-depth research and clinical management of various primary and secondary kidney diseases, such as glomerulonephritis, nephrotic syndrome, diabetic nephropathy, and hypertensive renal damage. A key component of this department is the PD Center (Peritoneal Dialysis Center), which manages more than 450 patients on chronic PD and performs an average of 10 PD catheter insertions per month. The PD Center offers a structured residency and fellowship program, including theoretical learning, practical PD experience (outpatient, inpatient, and remote management), observation of PD catheter surgery, and participation in Continuous Quality Improvement (CQI) programs. Research at the PD Center focuses on protein-energy wasting, peritonitis, and cognitive function in PD patients, having published over 70 SCI-cited papers. The center also provides dedicated training opportunities for nurses.

Obstetrics and Gynecology (妇产科): Approved as a national clinical key specialty in 2010, the Obstetrics and Gynecology department at Peking University First Hospital is noted for its extensive experience and advanced technologies. It provides comprehensive diagnosis and treatment for a broad spectrum of conditions, including uterine fibroids, endometriosis, gynecological endocrine diseases, pelvic inflammation, reproductive tract infectious diseases, female urinary incontinence, ovarian cancer, cervical cancer, endometrial cancer, and vulvar cancer. The hospital operates a dedicated Women and Children's Hospital located at No. 1 Xi'anmen Street.

Pediatrics (儿科): The Pediatrics department is a national-level key discipline with a rich history and deep clinical expertise in diagnosing and treating childhood diseases. It established the first Pediatrics Teaching and Research Office in China in 1929 and the first Pediatric Neurology department in China in 1961. The department is particularly strong in pediatric critical care medicine, providing specialized treatment for complex and critical conditions such as sepsis, neurological critical diseases, and genetic metabolic crises in children. In a significant development, the Children's Medical Center of Peking University First Hospital was unveiled on June 18, 2024, marking a new phase in pediatric medicine and resource integration. The department is located at No.1, Xi’anmen Street and is also involved in advanced research, including the study of induced pluripotent stem cells (iPSC).

Cardiology (心血管内科): Recognized as a national key specialty, the Cardiology department demonstrates a high level of expertise in the diagnosis and treatment of various cardiovascular diseases, including coronary heart disease, arrhythmia, heart failure, and hypertension. The hospital established the first Cardiovascular Ward in a general hospital in China during the 1950s and was a pioneer in performing interventional treatments for coronary heart disease. The department's focus on cardiovascular health is further supported by JBI's Evidence-Based Practice (EBP) Database campaigns, which highlight evidence-based clinical decision support for this specialty.

Respiratory and Critical Care Medicine (呼吸和危重症医学科): This department is a national clinical key specialty known for its extensive clinical experience and advanced diagnostic and treatment technologies. It specializes in managing respiratory critical diseases, diffuse lung diseases, sleep-related breathing disorders, lung tumors, and chronic respiratory diseases. As part of Peking University First Hospital, which performs over 44,000 surgeries annually, this department contributes significantly to complex medical interventions.

Rheumatology and Immunology (风湿免疫科): Selected as a national clinical key specialty in 2021, the Department of Rheumatology and Immunology was founded in 2007. It primarily diagnoses and treats a wide range of rheumatic and immune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and connective tissue disease-related pulmonary hypertension. The department is particularly proficient in the diagnosis and treatment of various types of arthritis, with a special focus on rheumatoid arthritis.

Dermatology and Venereology (皮肤性病科): As a national-level key discipline, the Department of Dermatology at Peking University First Hospital boasts a century-long legacy, having been founded in 1915 as the first national dermatology discipline. It is home to the National Clinical Research Center for Skin and Immune Diseases (approved in 2019, the sole center in this field) and the NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics (approved in 2021). The department has been pivotal in advancing dermatology in China, with historical figures like Professor Hu Chuan-kuei, who led efforts to eradicate venereal diseases, and Professor Wang Guangchao, the first Chinese dermatologist to lead an international academic organization. The department's mission emphasizes "innovation and transformation aimed at clinical application," driving collaborations with enterprises to develop new concepts, technologies, drugs, devices, and standards with independent intellectual property rights. It actively promotes the standardization of dermatology care nationwide through its extensive collaboration network with nearly 400 tertiary and over 200 secondary hospitals. Key research areas include life-threatening skin tumors, severe autoimmune skin diseases, allergic/inflammatory skin diseases, infectious skin diseases, and cosmetic efficacy evaluation, supported by advanced platforms in multi-omics, big data, AI, and medical aesthetics.

Plastic and Burn Surgery (整形烧伤外科): Designated as a national clinical key specialty in 2021, the Plastic and Burn Surgery department offers a comprehensive professional facility system and team. This includes specialized cosmetic plastic surgery clinics, advanced wound treatment centers, dedicated plastic and burn wards, and outpatient operating rooms. The department possesses extensive experience and utilizes advanced technologies in areas such as cosmetic plastic surgery, oncoplastic surgery, and wound management.